Clinical Trial Update: A Prospective Pharmacodynamic Study of Rivaroxaban

View source ↗

Summary

The document reports the completion of a prospective pharmacodynamic study of rivaroxaban.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Blood Clot | Status: COMPLETED